Literature DB >> 11327717

GATA DNA-binding protein expressed in mouse I-10 Leydig testicular tumor cells.

R Nakagawa1, Y Sakai, A Takashima, T Terada, A Kobayashi, M Maeda.   

Abstract

A nuclear extract of the mouse I-10 Leydig tumor cell line was analyzed by gel mobility shift assay with a combination of antibodies for various mammalian GATA proteins. Antibodies for GATA-4 caused a super-shift of the DNA-protein complex, which is formed through GATA-4 binding to an oligonucleotide with a typical GATA motif, while ones for GATA-1, GATA-2, GATA-3, and GATA-6 did not. These results indicated that I-10 cells express GATA-4 protein. Western blotting analysis of cellular proteins also demonstrated the presence of GATA-4 protein, the size of which corresponds to that of the rat orthologous protein transiently expressed in Cos-1 cells. A significant level of GATA-4 expression in I-10 cells would be advantageous for studying the roles of this protein, especially in view of gonadal function. We further examined the binding site preference of GATA-4 expressed in I-10 cells. GATA-4 showed broad sequence specificity similar to GATA-6, the order of binding core site preference being GATA > GATT > GATC, and adenine was favored on both sides of the core for strong binding. Thus the conserved zinc finger domain of GATA proteins is suggested to contribute to the binding sequence preference. GATA-4 expressed in I-10 cells was not susceptible to proteolysis coupled with cAMP signaling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11327717     DOI: 10.1006/bbrc.2001.4802

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  1 in total

1.  GATA augments GNRH-mediated increases in Adcyap1 gene expression in pituitary gonadotrope cells.

Authors:  Robin L Thomas; Natalie M Crawford; Constance M Grafer; Weiming Zheng; Lisa M Halvorson
Journal:  J Mol Endocrinol       Date:  2013-11-07       Impact factor: 5.098

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.